Last reviewed · How we verify
NCT05807802
FSTL1 and PPCs on Pediatric Within LDLT:a Prospective Cohort Analysis
trial in Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) in 400 participants. Status unknown.
31 May 2024
Quick facts
| Lead sponsor | Tianjin First Central Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 May 2023 |
| Primary completion | 31 May 2024 |
| Estimated completion | 31 December 2024 |
Conditions studied
- Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) — all drugs for Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) →
- Pulmonary Complication — all drugs for Pulmonary Complication →
- Liver Transplant; Complications — all drugs for Liver Transplant; Complications →
Sponsor
Tianjin First Central Hospital
Who can join
Adults 3 Months to 5, any sex, with Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) or Pulmonary Complication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to identify the association between FSTL1 elevation and acute lung injury (ALI) after pediatric liver transplantation.The main questions it aims to answer what the risk factors are for ALI in children and to evaluate the predictive value for the development of ALI.Participants will be divided into non-ALI group and ALI group according to whether they had ALI in a week after liver transplantation.Researchers will compare the difference between the two groups and use multivariate logistic regression analysis to screen the risk factors of ALI, and receiver operating characteristic(ROC) curve was used to evaluate the predictive efficacy of risk factors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05807802
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Currently open trials in the same condition.
- NCT06805409 — VExUS in Ards Patients and Association with AKI · recruiting
- NCT06123962 — ALI/ARDS Clinical Sub-phenotyping Study · recruiting
- NCT05002478 — Infants with Severe Acute Respiratory Distress Syndrome: the Prone Trial · NA · recruiting
Other Tianjin First Central Hospital trials
Trials by the same sponsor.
- NCT06598228 — Acute Kidney Injury and Recovery Mode in Pediatric Liver Transplantation · completed
- NCT05752058 — Risk Factors for Early Acute Lung Injury After Liver Transplantation in Children · unknown
- NCT05926076 — COVID-19 Infection · unknown
- NCT05783518 — Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients · Phase 4 · unknown
- NCT03904485 — Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05807802 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tianjin First Central Hospital
- Last refreshed: 13 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05807802.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing